Literature DB >> 35418444

Ethics of sedation for existential suffering: palliative medicine physician perceptions - qualitative study.

Paulo Rodrigues1, Jozefien Ostyn2, Sarah Mroz3, Axelle Ronsse2, Johan Menten4, Chris Gastmans2.   

Abstract

OBJECTIVES: Palliative sedation for existential suffering (PS-ES) is considered a controversial practice to control refractory suffering at the end of life. This study aims to explore Belgian palliative care physicians' perceptions regarding the ethics of PS-ES.
METHODS: This nationwide qualitative study follows a Grounded Theory approach. We conducted semistructured interviews with 25 palliative care physicians working in 23 Belgian hospitals and hospices (Flanders, Brussels, Wallonia). We analysed the data using the Qualitative Analysis Guide Of Leuven and we followed the Consolidated Criteria for Reporting Qualitative Research guidelines.
RESULTS: The data revealed that Belgian palliative care physicians have difficulty characterising ES and distinguishing it from other types of suffering. They express mixed attitudes towards PS-ES and employ a wide range of ethical arguments in favour and against it, which are mainly linked to the four principles of biomedical ethics.
CONCLUSION: Since there is a lack of consensus among Belgian palliative care physicians about PS-ES, further research is needed to clarify their attitudes. A better understanding of physicians' underlying presuppositions can provide more insight into their perceptions of ES and PS-ES and provide further insight for establishing good practices in ES management at the end of life. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  end of life care; ethics; terminal care

Year:  2022        PMID: 35418444     DOI: 10.1136/bmjspcare-2021-003395

Source DB:  PubMed          Journal:  BMJ Support Palliat Care        ISSN: 2045-435X            Impact factor:   3.568


  1 in total

1.  Medical decision-making in hospices from the viewpoint of physicians: results from two qualitative studies.

Authors:  Andreas Walker; Christof Breitsameter
Journal:  BMC Palliat Care       Date:  2022-09-10       Impact factor: 3.113

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.